What is the appropriate evaluation and management for an adult patient with elevated monocyte count (monocytosis) on a routine complete blood count?

Evaluation and Management of Elevated Monocyte Count

For an adult with elevated monocytes on routine CBC, first exclude reactive causes (infection, inflammation, malignancy), then if monocytosis is persistent (>1×10⁹/L for ≥3 months) or absolute monocyte count >0.5×10⁹/L with concerning features, proceed with comprehensive hematologic workup to exclude chronic myelomonocytic leukemia (CMML) and other myeloid neoplasms.

Initial Assessment: Distinguish Reactive from Clonal Monocytosis

The first critical step is determining whether monocytosis is reactive or potentially clonal. Reactive monocytosis is far more common and occurs with infections (particularly bacterial), inflammatory conditions, smoking, obesity, medications, asplenia, and solid tumors 1, 2.

Key Clinical Features to Assess:

• Symptoms suggesting malignancy: Fever, unintentional weight loss, night sweats, easy bruising, fatigue 2
• Splenomegaly or hepatomegaly on physical examination 1
• Cutaneous lesions (monocytic infiltration) 1
• Cytopenias in other cell lines (anemia, thrombocytopenia) 1
• Persistence: Monocytosis lasting ≥3 months is more concerning for clonal disease 1

Diagnostic Thresholds and When to Pursue Further Workup

Absolute Monocyte Count Thresholds:

• >1×10⁹/L: Traditional CMML threshold, but recent classifications have lowered this 1
• >0.5×10⁹/L: New threshold in WHO5 and ICC classifications for CMML 3
• ≥0.6×10⁹/L or ≥0.95×10⁹/L: Associated with clonal hematopoiesis in community studies 4, 5

Important caveat: Monocyte counts increase with age and are higher in men 5. Consider sex-specific and age-specific reference ranges when interpreting results.

Comprehensive Hematologic Workup (When Indicated)

Proceed with full evaluation if:

• Persistent monocytosis ≥3 months without clear reactive cause
• Absolute monocyte count >0.5×10⁹/L with cytopenias or concerning symptoms
• Any suspicious features on peripheral smear

Required Diagnostic Studies 1:

Peripheral Blood:

• Complete blood count with differential
• Peripheral blood smear examination looking for:
  • Dysgranulopoiesis
  • Promonocytes, blasts, immature myeloid cells
  • Monocyte morphology

Bone Marrow Evaluation:

• Bone marrow aspiration and biopsy to assess:
  • Dysplasia in myeloid lineages
  • Blast percentage (must be <20% for CMML)
  • Marrow cellularity and fibrosis
  • Megakaryocyte morphology

Cytogenetic and Molecular Studies:

• Conventional cytogenetics to detect clonal abnormalities
• BCR-ABL1 fusion gene testing (molecular assay) to exclude chronic myeloid leukemia 1
• PDGFRA and PDGFRB rearrangement testing if eosinophilia present 1

Flow Cytometry:

• Monocyte subset partitioning (the "monocyte assay"): Classical monocytes >94% of total monocytes supports CMML diagnosis 6
• Assessment for aberrant monocyte immunophenotype 1

CMML Diagnostic Criteria (WHO 2008, Still Relevant) 1:

1. Persistent peripheral blood monocytosis >1×10⁹/L (or >0.5×10⁹/L in newer classifications)
2. No Philadelphia chromosome or BCR-ABL1 fusion gene
3. No PDGFRA or PDGFRB rearrangement
4. <20% blasts in blood and bone marrow
5. At least one of:
   • Dysplasia in ≥1 cell lines
   • Acquired clonal cytogenetic/molecular abnormality
   • Persistent monocytosis ≥3 months with no other cause

Clonal Hematopoiesis Considerations

Recent population studies reveal that monocytosis with clonal hematopoiesis (CH) does not always indicate CMML 4, 5. However:

• CMUS (Clonal Monocytosis of Undetermined Significance) and CCMUS are high-risk entities associated with progression to myeloid neoplasia 5
• Mutations in SRSF2, TET2, ASXL1, NRAS, KRAS, CBL are common in CMML 1
• Isolated DNMT3A mutations with monocytosis are less concerning and often represent age-related CH 5
• Multiple mutations or spliceosome mutations (especially SRSF2) increase concern for clonal monocytic proliferation 4

Common Pitfalls to Avoid

1. Not repeating CBC: Transient monocytosis is common; confirm persistence before extensive workup
2. Ignoring reactive causes: Always exclude infection, inflammation, and solid tumors first 1
3. Missing CMML in older patients: CMML median age is 65-75 years with male predominance 1
4. Overlooking cytopenias: Anemia (Hgb <12 g/dL) is a poor prognostic factor in CMML 1
5. Failing to distinguish MD-CMML from MP-CMML: WBC count <13×10⁹/L suggests dysplastic variant, which may have different therapeutic implications 1

When to Refer to Hematology

Immediate referral if:

• Persistent monocytosis with cytopenias
• Blasts or immature myeloid cells on peripheral smear
• Splenomegaly with monocytosis
• Constitutional symptoms (fever, weight loss, night sweats)
• Cannot exclude malignancy based on initial evaluation 2

Consider referral if:

• Monocytosis persists >3 months without clear cause
• Absolute monocyte count >0.95×10⁹/L in older adults 4, 5